title: Susceptibility of periodontopathogenic and cariogenic bacteria to defensins and potential therapeutic use of defensins in oral diseases.
abstract: Antimicrobial peptides play an important role in the human innate immune defense system. In the oral cavity, a number of antimicrobial peptides, including defensins and LL37, are produced from various tissues such as salivary glands, gingival epithelium, tongue and buccal mucosa. These peptides are believed to function as a host defense system by controlling the activities of commensal bacteria and thus preventing the colonization and growth of pathogenic bacteria in oral cavity. Two major oral diseases, dental caries and periodontitis are known as infectious diseases. Therefore, it is of great interest to elucidate the mechanisms underlying the onset and progression of these diseases by investigating the interaction between cariogenic, or periodontopathogenic bacteria and antimicrobial peptides. Since these peptides have a broad antimicrobial spectrum, they are implicated as possible therapeutic agents. Therefore, in this review, we first focus on the susceptibility of oral bacteria, especially cariogenic and periodontopathogenic bacteria, to antimicrobial peptides, and then we discuss their potential diagnostic and clinical therapeutic uses.
authors.affiliation: Department of Bacteriology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima 734-8553, Japan. hkomatsu@hiroshima-u.ac.jp
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Komatsuzawa
authors.forename: Kazuhisa
authors.initials: K
authors.lastname: Ouhara
authors.forename: Toshihisa
authors.initials: T
authors.lastname: Kawai
authors.forename: Sakuo
authors.initials: S
authors.lastname: Yamada
authors.forename: Tamaki
authors.initials: T
authors.lastname: Fujiwara
authors.forename: Hideki
authors.initials: H
authors.lastname: Shiba
authors.forename: Hidemi
authors.initials: H
authors.lastname: Kurihara
authors.forename: Martin A
authors.initials: MA
authors.lastname: Taubman
authors.forename: Motoyuki
authors.initials: M
authors.lastname: Sugai
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use; D023181:Antimicrobial Cationic Peptides / Q000502:physiology / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects*; D018407:Bacterial Physiological Phenomena; D054804:Cathelicidins; D023082:Defensins / Q000502:physiology / Q000627:therapeutic use; D003731:Dental Caries / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D010518:Periodontitis / Q000188:drug therapy / Q000382:microbiology*
chemical_list: D000890:Anti-Infective Agents; D023181:Antimicrobial Cationic Peptides; D054804:Cathelicidins; D023082:Defensins